U.S. Markets open in 7 hrs 19 mins

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Has Attractive Fundamentals

Simply Wall St

Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card!

LeMaitre Vascular, Inc. (NASDAQ:LMAT) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the case of LMAT, it is a company with great financial health as well as a a strong history of performance. Below, I’ve touched on some key aspects you should know on a high level. For those interested in understanding where the figures come from and want to see the analysis, take a look at the report on LeMaitre Vascular here.

Flawless balance sheet with proven track record

LMAT has a strong track record of performance. In the previous year, LMAT delivered an impressive double-digit return of 15% Unsurprisingly, LMAT surpassed the industry return of 6.9%, which gives us more confidence of the company’s capacity to drive earnings going forward. LMAT is financially robust, with ample cash on hand and short-term investments to meet upcoming liabilities. This suggests prudent control over cash and cost by management, which is a key determinant of the company’s health. Investors should not worry about LMAT’s debt levels because the company has none! This implies that the company is running its operations purely on off equity funding. which is typically normal for a small-cap company. Therefore the company has plenty of headroom to grow, and the ability to raise debt should it need to in the future.

NasdaqGM:LMAT Income Statement, March 23rd 2019

Next Steps:

For LeMaitre Vascular, there are three key factors you should further examine:

  1. Future Outlook: What are well-informed industry analysts predicting for LMAT’s future growth? Take a look at our free research report of analyst consensus for LMAT’s outlook.
  2. Valuation: What is LMAT worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether LMAT is currently mispriced by the market.
  3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of LMAT? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.